$MGLN (Magellan Health, Inc.)

$MGLN {{ '2016-07-05T13:07:24+0000' | timeago}} • Announcement

$MGLN said it has completed its acquisition of Armed Forces Services Corp. (AFSC). AFSC holds about 60 contracts with federal government, and has 1,800 employees and subcontractors, with operations in all 50 states, 3 territories and 8 countries. $MGLN will update its 2016 guidance to include impact of acquisition on next earnings call on July 29.

$MRK {{ '2017-07-28T15:52:14+0000' | timeago}} • Announcement

Pharma segment, $MRK's only reportable segment and money-spinner, rose modestly to $8.76Bil. Growth was mainly due to new product launches offset by generic drug launches from competition and lower diabetes drug sales. Merck also narrowed and raised its 2017 revenue outlook to $39.4-40.4Bil, but reduced its 2017 GAAP EPS forecast to $1.60-1.72.

$MRK {{ '2017-07-28T15:26:51+0000' | timeago}} • Announcement

Pharma giant $MRK reported better-than-expected sales due to strong demand from its cancer drug KEYTRUDA. Sales for KEYTRUDA tripled to $881MM vs. $314MM in 2Q16. Drugmarker also disclosed that cyber-attack (June 27) had a dent on its operations. Magnitude of the disruption is yet to be ascertained, as $MRK tries to restore from the attack.

$MRK {{ '2017-07-28T13:05:50+0000' | timeago}} • Infographic

$MRK Merck Earnings AlphaGraphic: Q2 2017 Highlights

$CYH {{ '2017-07-27T12:33:35+0000' | timeago}} • Announcement

Hospital operator $CYH said it expects 2Q17 operating revenue to be about $4.1Bil, lower than $4.6Bil recorded last year. The company sees a net loss of $137MM or $1.22 per share for the quarter, compared to the $1.431Bil loss recorded in 2Q16. Adjusted EBITDA is estimated at $435MM, compared to $563MM a year earlier.

$MRK {{ '2017-07-26T13:49:00+0000' | timeago}} • Announcement

$MRK's BoD declared a quarterly dividend of $0.47 per share of its common stock for 4Q17. The dividend will be paid on Oct. 6, 2017 to shareholders of record at the close of business on Sept. 15, 2017.

$MRK {{ '2017-07-25T17:08:10+0000' | timeago}} • Announcement

$MRK announced the presentation of results from the Drive-Ahead study, the second of two pivotal Phase 3 clinical trials evaluating the efficacy and safety of doravirine, the company's investigational, non-nucleoside reverse transcriptase inhibitor (NNRTI), for the treatment of HIV-1 infection.

$MRK {{ '2017-07-25T11:50:57+0000' | timeago}} • Announcement

$MRK said that its anti-programmed cell death protein 1 (PD1) drug Keytruda (pembrolizumab) failed to meet the primary endpoint in the Phase III KEYNOTE-040 trial for previously treated recurrent or metastatic head and neck squamous cell carcinoma (HNSCC). When compared with standard treatment, Keytruda failed to improve the overall survival rate.

$MRK {{ '2017-07-24T18:28:47+0000' | timeago}} • Announcement

$MRK today announced the US launch of RENFLEXIS, a biosimilar for Remicade, which was approved by FDA for all eligible indications. RENFLEXIS will have a wholesale acquisition cost of $753.39, which is a 35% discount compared to Remicade. Remicade was the fifth bestselling drug in the US in 2016 raking in $5.3Bil on an invoice price basis.

$CYH {{ '2017-07-24T10:52:14+0000' | timeago}} • Announcement

$CYH's subsidiaries agreed to sell 126-bed Highlands Regional Medical Center in Sebring, Florida, and its associated assets to subsidiaries of $HCA. The transaction is expected to close in the fall of 2017.

$HCA {{ '2017-07-21T20:39:36+0000' | timeago}} • Announcement

$HCA has agreed to acquire Highlands Regional Medical Center in Sebring, Florida, from subsidiaries of Community Health Systems, Inc. The transaction, which is subject to regulatory approvals and other closing conditions, is expected to close in the fall of 2017.

$MRK {{ '2017-07-21T15:21:07+0000' | timeago}} • Announcement

President Donald Trump announced that pharma giants $MRK and $PFE are collaborating with Gorilla Glass manufacturer Corning ($GLW) for manufacturing a new glass (Valor Glass), which is superior and reliable for the delivery of injectable drugs. Corning is planning to initially invest $500MM creating 1,000 jobs at 3 facilities in US.

$MRK {{ '2017-07-20T14:29:27+0000' | timeago}} • Announcement

$MRK announced that the U.S. Food and Drug Administration (FDA) has granted tentative approval for its 100 units/mL insulin glargine injection, a follow-on biologic basal insulin in a pre-filled dosing device.

$HLS {{ '2017-07-20T13:56:35+0000' | timeago}} • Announcement

The BoD of $HLS declared a quarterly cash dividend on its common stock of $0.25 per share. The dividend is payable on Oct. 16, 2017, to stockholders of record on Oct. 2, 2017.

$UHS {{ '2017-07-19T22:35:19+0000' | timeago}} • Announcement

$UHS BoD approved a cash dividend of $0.10 per share on Sept. 15, 2017 to shareholders of record as of Sept. 1, 2017.

$UNH {{ '2017-07-18T21:56:14+0000' | timeago}} • Webcast

In Optum segment, $UNH is focusing on three key areas for growth; strong sales pipeline of $40Bil, growing YTD sales and backlog. On MedicareAdvantage, the company expects to outperform the market in 2018 with a positive long-term outlook for the industry. $UNH also feels that the return of insurer's fee will be the single largest headwind in 2018.

$UNH {{ '2017-07-18T21:51:39+0000' | timeago}} • Webcast

Despite forgoing over $1.8Bil in revenues due to the withdrawal from the ACA individual insurance market and the health insurance tax moratorium, $UNH revenues increased nearly 9% to $40.8Bil. Health insurer also announced that the partnership with AARP will continue through at least 2025 to offer Medicare related products under AARP brand.

$UNH {{ '2017-07-18T21:48:14+0000' | timeago}} • Webcast

Health insurance giant $UNH said it served 2.5MM more people in 2Q17 vs. 2Q16, excluding the individual market. The business model of the insurer is focused on addressing the healthcare needs of consumers in areas like group Medicare Advantage, Medicaid programs in emerging markets like Brazil and established markets.

$UNH {{ '2017-07-18T21:45:28+0000' | timeago}} • Webcast

$UNH expects its stellar performance in first half to carry forward in the second half of 2017 and into 2018. On a global basis, the insurer serves 139MM people, including 126MM in the United States. UnitedHealth believes it is on target to exceed the $200Bil mark in 2017 for the first time.

$UNH {{ '2017-07-18T14:47:02+0000' | timeago}} • Announcement

$UNH's 2Q revenues increased approx. 8% crossing $50Bil. The insurer is on target to reach annual revenues of $200Bil for the first time. Total enrollment jumped 3% to 49.5MM people. Medical care ratio (MCR), a key indicator to measure financial health of insurance firms, increased 20 bps reaching 82.2%, in line with industry standards.

$UNH {{ '2017-07-18T14:46:13+0000' | timeago}} • Announcement

$UNH, the largest health insurer in US, reported stellar results in 2Q17 backed by the growth from its Optum segment. The insurance giant raised its 2017 outlook. $UNH now expects its 2017 GAAP EPS to be $9.20-9.35 and adjusted EPS to be $9.75-9.90. UnitedHealth is the first firm in its industry to report earnings every quarter.

Recent Transcripts

MRK (Merck & Co. Inc.)
Friday, July 28 2017 - 12:00pm
UHS (Universal Health Services Inc.)
Wednesday, July 26 2017 - 1:00pm
ANTM (Anthem, Inc.)
Wednesday, July 26 2017 - 12:30pm
HCA (HCA Holdings, Inc.)
Tuesday, July 25 2017 - 2:00pm
CNC (Centene Corp.)
Tuesday, July 25 2017 - 12:30pm
UNH (UnitedHealth Group Incorporated)
Tuesday, July 18 2017 - 12:45pm
ONVO (Organovo Holdings, Inc.)
Wednesday, June 7 2017 - 9:00pm
PTN (Palatin Technologies Inc.)
Tuesday, May 16 2017 - 3:00pm
FVE (Five Star Quality Care Inc.)
Friday, May 5 2017 - 2:00pm
SEM (Select Medical Holdings Corporation)
Friday, May 5 2017 - 1:00pm
CI (Cigna Corp.)
Friday, May 5 2017 - 12:30pm
SYN (Synthetic Biologics Inc.)
Thursday, May 4 2017 - 8:30pm
MD (MEDNAX, Inc.)
Thursday, May 4 2017 - 2:00pm
KND (Kindred Healthcare Inc.)
Thursday, May 4 2017 - 1:00pm
FMS (Fresenius Medical Care AG & Co. KGAA)
Wednesday, May 3 2017 - 1:30pm
HUM (Humana Inc.)
Wednesday, May 3 2017 - 1:00pm
EVHC (Envision Healthcare Holdings, Inc.)
Tuesday, May 2 2017 - 9:00pm
CYH (Community Health Systems, Inc.)
Tuesday, May 2 2017 - 4:00pm
HCA (HCA Holdings, Inc.)
Tuesday, May 2 2017 - 3:00pm
THC (Tenet Healthcare Corp.)
Tuesday, May 2 2017 - 2:00pm

AlphaGraphics you may like